<DOC>
<DOCNO>
EP-0004040
</DOCNO>
<TEXT>
<DATE>
19790919
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/19 A61K-31/403 A61K-31/185 A61K-31/405 A61K-31/195 A61K-31/60 <main>A61K-31/195</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
pharmaceutical compositions having analgesic properties comprising a compound selected from d- and dl-phenylalanine, d- and dl-leucine and hydrocinnamic acid in the unit dose of at least 200mg.
</TITLE>
<APPLICANT>
merck patent gmbhde<sep>merck patent gesellschaft mit beschrankter haftung <sep>merck patent gmbhpostfach, frankfurter strasse 250d-64271 darmstadt de  <sep>merck patent gesellschaft mit beschrankter haftung<sep>
</APPLICANT>
<INVENTOR>
balagot reuben c<sep>comaty joseph e<sep>ehrenpreis seymour<sep>balagot, reuben c.<sep>comaty, joseph e.<sep>ehrenpreis, seymour<sep>balagot, reuben c.4264 n. hazelchicago illinois 60613us<sep>comaty, joseph e.1471 brown streetdes plaines illinois 60016us<sep>ehrenpreis, seymour4339 birchwood avenueskokie illinois 60076us<sep>balagot, reuben c.  <sep>comaty, joseph e.<sep>ehrenpreis, seymour<sep>balagot, reuben c.4264 n. hazelchicago illinois 60613us<sep>comaty, joseph e.1471 brown streetdes plaines illinois 60016us<sep>ehrenpreis, seymour4339 birchwood avenueskokie illinois 60076us<sep>
</INVENTOR>
<ABSTRACT>
a new class of analgesics is provided by substances that  inhibit breakdown of endogenous substances such as  enkephalins and/or endorphins.  the analgesic effect of an  enkephalin breakdown inhibitor is greatly enhanced by being  combined with an antipyretic, anti-inflammatory analgesic,  herein designated as an aspirin-type drug.  specifically, both  d-phenylalanine and d-leucine, each an enkephalin breakdown  inhibitor, when used separately provides excellent  analgesia in animals and man without developing tolerance  or addiction in either species.  use of a combination of  d-phenylalanine and d-leucine provides a greatly enhanced  analgesia approaching the analgesia achieved by morphine.   analgesia by the latter combination is very long-lasting in  animals.  the injection of a combination of d-phenylalanine  and an aspirin-like drug that is antipyretic and antiinflammatory,  in an animal provides a greatly enhanced  analgesia approaching the analgesia achieved by morphine.   analgesia by d-phenylalanine is very long-lasting in  humans.  
</ABSTRACT>
</TEXT>
</DOC>
